Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular and Cellular Biology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.23.7.2225-2238.2003PMID 12640109PMCID PMC150734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells.

  2018cited by this paper
• BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair

  2002cited by this paper
• HMGI/Y proteins: flexible regulators of transcription and chromatin structure.

  2001cited by this paper
• Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway

  2001cited by this paper
• Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

  2001cited by this paper
• High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases

  2001cited by this paper
• Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells

  2001cited by this paper
• Estrogens, BRCA1, and breast cancer.

  2000cited by this paper
• Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation.

  2000cited by this paper
• Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.

  2000cited by this paper
• Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

  2000cited by this paper
• Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.

  2000cited by this paper
• Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.

  2000cited by this paper
• Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.

  2000cited by this paper
• Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.

  2000cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• Sequence analysis of the rat Brca1 homolog and its promoter region

  1999cited by this paper
• Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.

  1999cited by this paper
• Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

  1999cited by this paper
• Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999influential reference
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Positive Regulation of the BRCA1 Promoter*

  1999cited by this paper
• Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

  1999cited by this paper
• Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene.

  1999cited by this paper
• HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.

  1999cited by this paper
• Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation

  1999cited by this paper
• Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

  1998cited by this paper
• Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region

  1998cited by this paper
• Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix.

  1998cited by this paper
• Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.

  1998cited by this paper
• Estrogen upregulation of BRCA1 expression with no effect on localization

  1998cited by this paper
• Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype.

  1998cited by this paper
• BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

  1997cited by this paper
• Methylation of the BRCA1 gene in sporadic breast cancer.

  1997cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• Gatekeepers and caretakers

  1997cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.

  1996cited by this paper
• Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

  1996cited by this paper
• High level expression of the HMGI (Y) gene during embryonic development.

  1996cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Hormone-dependent regulation of BRCA1 in human breast cancer cells.

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995influential reference
• Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

  1995cited by this paper
• The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.

  1995cited by this paper
• Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.

  1993cited by this paper
• Transcriptional silencing in yeast is associated with reduced nucleosome acetylation.

  1993cited by this paper
• Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

  1993cited by this paper
• Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

  1991cited by this paper

• Natural compounds and programmed necrosis: pioneering a new frontier in cancer treatments

  2025cites this paper
• The deubiquitinating enzyme USP4 regulates BRCA1 stability and function

  2024cites this paper
• Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer

  2023cites this paper
• HMGA2 directly mediates chromatin condensation in association with neuronal fate regulation

  2023cites this paper
• Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

  2022cites this paper
• FMNL1 promotes growth and metastasis of breast cancer by inhibiting BRCA1 via upregulation of HMGA1

  2022cites this paper
• Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers

  2022cites this paper
• Low Expression of BRCA1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic Leukemia

  2022cites this paper
• A comprehensive review on oncogenic miRNAs in breast cancer

  2021cites this paper
• HMGA1 promotes hepatocellular carcinoma proliferation, migration, and regulates cell cycle via miR-195-5p

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• A comprehensive review on oncogenic miRNAs in breast cancer

  2021cites this paper
• Phosphorylation-regulated HMGA1a-P53 interaction unveils the function of HMGA1a acidic tail phosphorylations via synthetic proteins.

  2021cites this paper
• HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells

  2020cites this paper
• Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications

  2020cites this paper
• Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies

  2020cites this paper
• HMGA Proteins in Hematological Malignancies

  2020cites this paper
• HMGA Genes and Proteins in Development and Evolution

  2020cites this paper
• HMGA1 in cancer: Cancer classification by location

  2019cites this paper
• A molecular basis for Estrogen Receptor- α deficiency in BRCA1-linked breast cancer

  2019cites this paper
• A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus

  2018cites this paper
• The Linker Histone GH1-HMGA1 Is Involved in Telomere Stability and DNA Damage Repair1[OPEN]

  2018cites this paper
• High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.

  2018cites this paper
• Regulation of Tumor Progression by Programmed Necrosis

  2018cites this paper
• An Insight in Biomarkers for Colorectal Cancer

  2018cites this paper
• Ultrasensitive detection of cancer biomarkers using conducting polymer/electrochemically reduced graphene oxide-based biosensor: Application toward BRCA1 sensing

  2018cites this paper
• Practical consensus recommendations on management of triple-negative metastatic breast cancer

  2018cites this paper
• Epigenetics/Epigenomics of Olive Oil and the Mediterranean Diet

  2018cites this paper
• Targeting the PI 3 K / AKT / mTOR pathway in triple ‐ negative breast cancer : a review

  2018cites this paper
• Overexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma

  2018cites this paper
• Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis

  2018cites this paper
• Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

  2018cites this paper
• Critical role of HMGA proteins in cancer cell chemoresistance

  2017cites this paper
• Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression

  2017cites this paper
• Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

  2017cites this paper
• Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

  2017cites this paper
• Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

  2016cites this paper
• High-Mobility Group Box-1 Protein a Potential Inflammatory Biomarker in Diabetic Retinopathy

  2016cites this paper
• HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review

  2016cites this paper
• Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.

  2016cites this paper
• The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

  2016cites this paper
• The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair

  2016cites this paper
• TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

  2015cites this paper
• HMGA1 overexpression is associated with a particular subset of human breast carcinomas

  2015cites this paper
• Étude génomique et fonctionnelle de la dérégulation du gène HMGA2 dans les tumeurs adipocytaires

  2015cites this paper
• High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells.

  2015cites this paper
• Epigenetic Reduction of DNA Repair in Progression to Cancer

  2015cites this paper
• Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer*

  2015cites this paper
• Identifying long-range control elements of the BRCA1 promoter

  2015cites this paper
• Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.

  2015cites this paper
• Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis

  2015cites this paper
• relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis

  2015cites this paper
• Inhibition of poly(ADP-ribosyl)ation in cancer: old and new paradigms revisited.

  2014cites this paper
• Opportunities and hurdles in the treatment of BRCA1-related breast cancer

  2014cites this paper
• Serum high mobility group box protein 1 as a clinical marker for ovarian cancer.

  2014cites this paper
• Correlated Expression of HMGA2 and PLAG1 in Thyroid Tumors, Uterine Leiomyomas and Experimental Models

  2014cites this paper
• DEVELOPMENT OF A FUNCTIONAL ASSAY FOR DETERMINATION OF BRCA1 CARRIER STATUS

  2014cites this paper
• Why do Some People Inherit a Predisposition to Cancer? A small group activity on cancer genetics

  2014cites this paper
• Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle

  2013cites this paper
• DNA Damage, DNA Repair and Cancer

  2013influential citation
• Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer

  2013cites this paper
• The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR‐603 and miR‐10b expression

  2013cites this paper
• Epigenetic field defects in progression to cancer.

  2013cites this paper
• Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene.

  2013cites this paper
• Nrf 2 is associated with the regulation of basal transcription activity of the BRCA 1 gene

  2013cites this paper
• Identification of genes regulated by CBX7 protein and characterization of the transcriptional regulation mechanism of the SPP1 gene

  2013cites this paper
• PARP1 expression in breast cancer and effects of its inhibition in preclinical models

  2012cites this paper
• Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas

  2012cites this paper
• Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation

  2012cites this paper
• High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells.

  2012cites this paper
• Electrochemical Biosensors for Measurement of Genetic Biomarkers of Cancer

  2012cites this paper
• DNA repair genes BRCA1 and DNA-PKcs have great potential in radiation therapy

  2012cites this paper
• HMGB1 and its physiological and pathological roles.

  2012cites this paper
• Insights into the targeted elimination of BRCA1‐defective cancer stem cells

  2012influential citation
• High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria

  2012cites this paper
• Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

  2012cites this paper
• Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation

  2012cites this paper
• Molecular Determinants of Radiation Response

  2011cites this paper
• miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

  2011cites this paper
• Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

  2011cites this paper
• Inherited Mutations in Breast Cancer Genes—Risk and Response

  2011cites this paper
• Procédés pour classer et traiter les cancers du sein

  2011cites this paper
• Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

  2011cites this paper
• Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

  2011cites this paper
• Inhibitors of DNA Repair and Response to Ionising Radiation

  2011cites this paper
• PARP Inhibitors

  2011cites this paper
• Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene

  2011cites this paper
• Identification and Characterization of Novel Kinases that Regulate BRCA1 Expression and Function

  2010cites this paper
• HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

  2010cites this paper
• Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function.

  2010cites this paper
• High-Mobility Group A (HMGA) Proteins and Breast Cancer

  2010cites this paper
• HMGA and cancer.

  2010cites this paper
• HMGA1 protein expression in familial breast carcinoma patients.

  2010cites this paper
• Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer.

  2010cites this paper
• UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

  2010cites this paper
• Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.

  2010cites this paper
• BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer

  2010cites this paper
• BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions.

  2010cites this paper
• BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells

  2009cites this paper
• High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

  2009cites this paper